TNSN99225A1 - Formulations de doramectine antiparasitaires et procede pour leur preparation - Google Patents

Formulations de doramectine antiparasitaires et procede pour leur preparation

Info

Publication number
TNSN99225A1
TNSN99225A1 TNTNSN99225A TNSN99225A TNSN99225A1 TN SN99225 A1 TNSN99225 A1 TN SN99225A1 TN TNSN99225 A TNTNSN99225 A TN TNSN99225A TN SN99225 A TNSN99225 A TN SN99225A TN SN99225 A1 TNSN99225 A1 TN SN99225A1
Authority
TN
Tunisia
Prior art keywords
doramectin
preparation
formulations
pest control
formulation
Prior art date
Application number
TNTNSN99225A
Other languages
English (en)
Inventor
Denise Harding Valerie
Richard Wicks Stephen
Michael Lukas Timothy
Milojevic Snezana
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of TNSN99225A1 publication Critical patent/TNSN99225A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

L'INVENTION CONCERNE UNE FORMULATION COMPRENANT DE LA DORAMECTINE DANS UN SOLVANT COMPRENANT DE L'HUILE DE RICIN ET DE L'OLEATE D'ETHYLE OU DE L'HUILE DE COPRAH FRACTIONNEE ET DES AGENTS AUXILIAIRES SUPPLEMENTAIRES FACULTATIFS. ELLE CONCERNE EGALEMENT UN PROCEDE POUR SA PREPARATION. APPLICATION : UTILISATION DE CETTE FORMULATION POUR LUTTER CONTRE DES ENDO-OU ECTOPARASITES.
TNTNSN99225A 1998-12-16 1999-11-29 Formulations de doramectine antiparasitaires et procede pour leur preparation TNSN99225A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9827727.0A GB9827727D0 (en) 1998-12-16 1998-12-16 Antiparasitic formulations

Publications (1)

Publication Number Publication Date
TNSN99225A1 true TNSN99225A1 (fr) 2005-11-10

Family

ID=10844352

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN99225A TNSN99225A1 (fr) 1998-12-16 1999-11-29 Formulations de doramectine antiparasitaires et procede pour leur preparation

Country Status (21)

Country Link
US (1) US6699847B2 (fr)
EP (1) EP1140068B1 (fr)
JP (1) JP3848537B2 (fr)
AP (1) AP9901699A0 (fr)
AR (1) AR019499A1 (fr)
AT (1) ATE269074T1 (fr)
AU (1) AU762892B2 (fr)
BR (1) BR9916265A (fr)
CA (1) CA2355102C (fr)
DE (1) DE69918165T2 (fr)
DK (1) DK1140068T3 (fr)
ES (1) ES2221455T3 (fr)
GB (1) GB9827727D0 (fr)
GT (1) GT199900213A (fr)
MA (1) MA26710A1 (fr)
PA (1) PA8486601A1 (fr)
PE (1) PE20001244A1 (fr)
PT (1) PT1140068E (fr)
TN (1) TNSN99225A1 (fr)
TW (1) TW524691B (fr)
WO (1) WO2000035445A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003257778A1 (en) * 2002-08-02 2004-02-23 Shenzhen Salubris Pharmaceuticals Co., Ltd. A riboflavin derivative and its manufacture and uses
AU2003235019A1 (en) * 2003-08-17 2005-03-03 Sirene Call Pty Ltd Attract-and-Kill Method of Controlling Ecto-Parasites from the Order Acarina in Livestock and Domestic Animals as well as Members of the Order Artiodactyle
NZ590141A (en) * 2008-06-24 2012-05-25 Merial Ltd Anthelminthic formulations including castor oil and another vegetable oil
MX2009001235A (es) * 2008-09-19 2010-04-29 Agrovet Market S A Composicion y uso de un gel oral endoparasiticida bioadhesivo de larga accion a base de doramectina.
PL2396006T3 (pl) 2009-02-16 2013-06-28 Zoetis Llc Preparat zawierający doramektynę w dużej dawce
CN103417477B (zh) * 2012-05-18 2015-08-05 中国农业科学院兰州畜牧与兽药研究所 一种以水为基质的多拉菌素o/w型注射液及其制备方法
CN104822299B (zh) 2012-11-09 2018-11-20 伊莱克斯公司 拌合器
EA037747B1 (ru) * 2019-04-01 2021-05-18 Севиндж Аллахверди кызы АЛИЕВА Антипаразитарное средство

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL151903B (nl) 1965-03-24 1977-01-17 Schering Ag Werkwijze ter bereiding van een injectievloeistof door een steroid op te lossen in een mengsel van ricinusolie en benzylbenzoaat.
DE3377064D1 (en) 1982-12-28 1988-07-21 Bayer Ag Stable aminoglycoside-penicillin injection formulation
DE3484584D1 (de) 1983-10-14 1991-06-20 Sumitomo Pharma Injektionen mit verzoegerter abgabe.
CA1285874C (fr) 1985-08-23 1991-07-09 Thomas Harry Ferguson Formule injectable a liberation soutenue
ES2052173T3 (es) 1989-04-11 1994-07-01 Pfizer Composiciones inyectables que contienen 25-cyclohexil-avermectina b1.
NZ234802A (en) 1989-08-14 1992-11-25 Merck & Co Inc Long acting injectable formulations comprising an avermectin compound and triacetin. treatment for internal and external parasites of animals
ATE180671T1 (de) 1991-09-30 1999-06-15 Merck & Co Inc Hydrierte rizinusöl-enthaltende injizierbare formulierungen mit verlängerter wirkstoffabgabe
DE4410970C1 (de) 1994-03-29 1995-07-20 Talbot Waggonfab Wankstütze für Schienenfahrzeuge mit einer Querneigeeinrichtung
US5580574A (en) 1994-04-28 1996-12-03 Hoffmann-La Roche Inc. Pharmaceutical composition for transdermal delivery
WO1997011709A1 (fr) * 1995-09-25 1997-04-03 Ashmont Holdings Limited Compositions anthelmintiques a base de lactone macrocyclique
DE19613972A1 (de) * 1996-04-09 1997-10-16 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl
DE19638045A1 (de) * 1996-09-18 1998-03-19 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen
US6174540B1 (en) 1998-09-14 2001-01-16 Merck & Co., Inc. Long acting injectable formulations containing hydrogenated caster oil

Also Published As

Publication number Publication date
ATE269074T1 (de) 2004-07-15
PE20001244A1 (es) 2000-11-07
ES2221455T3 (es) 2004-12-16
PA8486601A1 (es) 2000-09-29
US6699847B2 (en) 2004-03-02
MA26710A1 (fr) 2004-12-20
WO2000035445A1 (fr) 2000-06-22
BR9916265A (pt) 2001-11-20
JP3848537B2 (ja) 2006-11-22
AU1069900A (en) 2000-07-03
DK1140068T3 (da) 2004-07-12
US20020142972A1 (en) 2002-10-03
DE69918165T2 (de) 2004-10-14
CA2355102C (fr) 2006-07-11
TW524691B (en) 2003-03-21
DE69918165D1 (de) 2004-07-22
GT199900213A (es) 2001-06-07
JP2002532422A (ja) 2002-10-02
AP9901699A0 (en) 2001-05-22
EP1140068B1 (fr) 2004-06-16
AR019499A1 (es) 2002-02-20
GB9827727D0 (en) 1999-02-10
CA2355102A1 (fr) 2000-06-22
PT1140068E (pt) 2004-09-30
EP1140068A1 (fr) 2001-10-10
AU762892B2 (en) 2003-07-10

Similar Documents

Publication Publication Date Title
MA25029A1 (fr) Formulations antiparasitaires contenant une avermectine ou milbemycine, et procede pour leur preparation.
TNSN98017A1 (fr) Derives de sulfonyluree, procede pour leur preparation et compositions pharmaceutiques les contenant.
ATE300533T1 (de) 1,2,3,4-tetrahydroisochinolin-derivate als urotensin ii rezeptor-antagonisten
TNSN99053A1 (fr) Hydroxamides d'acides (4-arylsulfonylamino)-tetrahydro- pyranne-4-carboxyliques), procede pour leur preparation et compositions les contenant
TNSN99172A1 (fr) 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant
BE2015C026I2 (en) 2-phenyl-1-[-(2-aminoethoxy)-benzyl -indole in combination with estrogens
DE69625374D1 (en) (methylsulfonyl)phenyl-2-(5h)-furanone als cox-2 inhibitoren
TR200102817T2 (tr) Antiinflamatuar ajanlar olarak faydalı bileşikler
DE3176125D1 (en) 1-carboxyalkanoylindolin-2-carboxylic acids and derivatives thereof, processes for their preparation, and pharmaceutical compositions containing these compounds
DE69935335D1 (de) Pyrazole als modulatoren des östrogenrezeptors
TNSN99125A1 (fr) Pyrrolo(2,3-d) pyrimidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
BR9611096B1 (pt) composição farmacêutica compreendendo um extrato estável de hypericum perforatum l.
WO1997030677A3 (fr) Pentafluorobenzenesulfonamides et analogues
HK1028548A1 (en) Formulations for hydrophobic pharmaceutical agents
CA2330500A1 (fr) Compositions pharmaceutiques gelifiables
DE60138709D1 (de) Analoge der barbitursäure als therapeutische wirkstoffe
DE69618820D1 (de) 3,4-diaryl-2-hydroxy-2,5-dihydrofurane als wirkstoffvorstufen von cox-2 inhibitoren
TNSN99225A1 (fr) Formulations de doramectine antiparasitaires et procede pour leur preparation
AP9801269A0 (en) Prostaglandin agonists.
CA2255229A1 (fr) Utilisation de l'acide cinnamique ou de ses derives dans une composition cosmetique raffermissante
EP0953331A3 (fr) Composition anhydre fluorée et produits cosmétiques ou de soins la contenant
TNSN01052A1 (fr) Metabolites du (-) - cis - 6 - phenyl - 5 - [4 -( 2-pyrrolidine -1- yl - ethoxy) - phenyl] - 5,6,7,8- tetrahydro - naphtalene - 2 - ol et compositions les contenant
WO2004055201A3 (fr) Cholesterol 24-hydroxylase (cyp46) utilisee en tant que cible therapeutique pour le traitement de la maladie d'alzheimer
ES2147973T3 (es) Estirenos alquilatados como profarmacos de inhibidores de cox-2.
DE69715173D1 (en) Bisarylcyclobutenderivate als cyclooxygenasehemmer